Delayed Enhancement on Cardiac Magnetic Resonance and Clinical, Morphological, and Electrocardiographical Features in Hypertrophic Cardiomyopathy

Journal of Cardiac Failure

Volumn 15, Issue 5, 2009, Pages 419-427

  Satoh, Hiroshi ^a   Matoh, Fumitaka ^a   Shiraki, Katsunori ^a   Saitoh, Takeji ^a   Odagiri, Keiichi ^a   Saotome, Masao ^a   Urushida, Tsuyoshi ^a   Katoh, Hideki ^a   Takehara, Yasuo ^a   Sakahara, Harumi ^a   Hayashi, Hideharu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac magnetic resonance; delayed enhancement; electrocardiogram; hypertrophic cardiomyopathy

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CLINICAL FEATURE; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QRS COMPLEX;

CARDIOMYOPATHY, HYPERTROPHIC; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 65649126359     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.11.014     Document Type: Article

References (33)

1. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
2. Maron B.J. Hypertrophic cardiomyopathy. In: Libby P., Bonow R.O., Mann D.L., Zipes D.P., and Braunwald E. (Eds). Braunwald's heart disease. A textbook of cardiovascular medicine. 8th ed (2007), Elsevier, Philadelphia 1763-1774
3. Gerber B.L., Garot J., Bluemke D.A., Wu K.C., and Lima J.A.C. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 106 (2002) 1083-1089
4. van Hoe L., and Vanderheyden M. Ischemic cardiomyopathy: value of different MRI techniques for prediction of functional recovery after revascularization. Am J Roentgenol 182 (2004) 95-100
5. Wagner A., Mahrholdt H., Holly T.A., Elliot M.D., Regenfus M., Parker M., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 (2003) 374-379
6. Matoh F., Hayashi H., Terada H., Satoh H., Katoh H., Urushida T., et al. Usefulness of delayed enhancement magnetic resonance imaging for detecting cardiac rupture caused by small myocardial infarction in a case of cardiac tamponade. Circ J 69 (2005) 1556-1559
7. Wilson J.M., Villareal R.P., Hariharan R., Massumi A., Muthupillai R., and Flamm S.D. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J 29 (2002) 176-180
8. Bogaert J., Goldstein M., Tannouri F., Golzarian J., and Dymarkowski S. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging. AJR Am J Roentgenol 180 (2003) 981-985
9. Teraoka K., Hirano M., Ookubo H., Sasaki K., Katsuyama H., Amino M., et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 22 (2004) 155-161
10. Amano Y., Takayama M., Takahama K., and Kumazaki T. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances. J Magn Reson Imaging 20 (2004) 595-600
11. Matsunaka T., Hamada M., Matsumoto Y., and Higaki J. First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI. Magn Reson Med Sci 2 (2003) 61-69
12. Moon J.C.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennel D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
13. Knaapen P., van Dockum W.G., Bondarenko O., Kok W.E., Gotte M.J., Boellaard R., et al. Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. J Nucl Med 46 (2005) 923-929
14. Varnava A.M., Elliott P.M., Baboonian C., Davison F., Davies M.J., and McKenna W.J. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 104 (2001) 1380-1384
15. Spirito P., Seidman C.E., McKenna W.J., and Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785
16. Matoh F., Satoh H., Shiraki K., Saitoh T., Urushida T., Katoh H., et al. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Cardiac Fail 13 (2007) 372-379
17. Harris K.M., Spirito P., Maron M.S., Maisch B., Mautner B., O'Connell J., et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114 (2006) 216-225
18. Richardson C., McKenna W., Bristow M., Casey S.A., Panse P., Panse N., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 93 (1996) 841-842
19. Rickers C., Wilke N.M., Jerosch-Herold M., and Pennell D.J. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112 (2005) 855-861
20. Moon J.C.C., Fisher N.G., McKenna W.J., and Wedeen V.J. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90 (2004) 645-649
21. Tseng W.Y., Dou J., Reese T.G., Zenovich A.G., Formisano F., Lesser J.R., et al. Imaging myocardial fiber disarray and intramural strain hypokinesis in hypertrophic cardiomyopathy with MRI. J Magn Reson Imaging 23 (2006) 1-8
22. Adabag AS, Maron BJ, MD, Appelbaum E, Harrigan CJ, Buros JJ, Gibson CM, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51:1369-1374.
23. Motoyasu M., Kurita T., Onishi K., Uemura S., Tanigawa T., Okinaka T., et al. Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by magnetic resonance imaging. Circ J 72 (2008) 378-383
24. Esposito A., De Cobelli F., Perseghin G., Pieroni M., Belloni E., Mellone R., et al. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at gadolinium delayed enhanced MR imaging. Heart (2008) [Epub ahead of print.]
25. Dumont C.A., Monserrat L., Soler R., Rodriguez E., Fernandez X., Peteiro1 J., et al. Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur Heart J 27 (2006) 1725-1731
26. Bongioanni S., Bianchi F., Migliardi A., Gnavi R., Pron P.G., and Casetta M. Conte, et al. Relation of QRS duration to mortality in a community-based cohort with hypertrophic cardiomyopathy. Am J Cardiol 100 (2007) 503-506
27. Papavassiliu T., Fluchter S., Haghi D., Suselbeck T., Wolpert C., Dinter D., et al. Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with Q waves in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 9 (2007) 595-604
28. Cosio F.G., Moro C., Alonso M., de la Calzada C.S., and Liovet A. The Q waves hypertrophic cardiomyopathy: an electrophysiologic study. N Engl J Med 10 (1980) 96-99
29. Sakamoto T., Tei C., Murayama M., Ichiyasu H., and Hada Y. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle: echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J 17 (1976) 611-629
30. Eriksson M.J., Sonnenberg B., Woo A., Rakowski P., Parker T.G., Wigle E.D., et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 39 (2002) 638-645
31. Matsubara K., Nakamura T., Kuribayashi T., Azuma A., and Nakagawa M. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 42 (2003) 288-295
32. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36 (2000) 2212-2218
33. Maron B.J. Contemporary considerations for risk stratification, sudden death and prevention in hypertrophic cardiomyopathy. Heart 89 (2003) 977-978